3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
5
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Biliary Tract Neoplasms
3
Nevi and Melanomas
2
Neoplastic Cells, Circulating
2
Neoplasm, Residual
2
Melanoma
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Recurrence
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Gastrointestinal Stromal Tumors
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Interventions
selinexor
2
Ifosfamide
2
Doxorubicin
2
pembrolizumab
1
pazopanib
1
metarrestin
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Proton Therapy
1
Nivolumab
1
Mesna
1
Liquid Biopsy
1
Injections
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neurofibrosarcoma
×
Liquid Biopsy
×
Clear all
NCT06515860
2026-01-09
NF1-TED
Boston Children's Hospital
Recruiting
1,000 enrolled